ClinicalTrials.Veeva

Menu

The Role of IL33/ST2 Axis in ARDS Patients

V

Vall d'Hebron University Hospital (HUVH)

Status

Completed

Conditions

Acute Respiratory Distress Syndrome

Study type

Observational

Funder types

Other

Identifiers

NCT02492204
IL33/ST2

Details and patient eligibility

About

The main objective is the study of the role of IL33/ST2 axis in the pathogenesis of ARDS, it´s value as prognosis marker and as therapeutic target.

Enrollment

200 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ARDS
  • Risk pathologies to develop ARDS (sepsis, pancreatitis, pneumonia, massive transfussion, politraumatics)

Exclusion criteria

  • Age under 18
  • Pregnancy
  • Undergoing a clinical trial

Trial design

200 participants in 2 patient groups

Survivors
Non survivors

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems